Expert Answers to Questions on PARP Inhibition for Prostate Cancer

Decera Clinical Education Oncology Podcast · Apr 6, 2021 · 10m

In this episode, Charles J. Ryan, MD, and Neal D. Shore, MD, FACS, answer questions from a healthcare professional audience on topics related to prostate cancer and PARP inhibition including:

Germline and somatic mutation testing

Managing adverse events with PARP inhibitors

Resistance to PARP inhibitors

Implications of monoallelic vs biallelic BRCA mutations

ATM mutations and PARP inhibitor sensitivity

Presenters:

Charles J. Ryan, MD

Professor of Medicine

B.J. Kennedy Chair in Clinical Medical Oncology

Director, Division of Hematology, Oncology and Transplantation

Department of Medicine…